Table 3.
Mean Concentrations E2, T, or 3α-diol in the Hippocampus of Aged Intact, Young Intact, and Young GDX Male Mice 1 h Following Administration of Vehicle or 1 mg/kg s.c. E2, T, or 3α-diol, 1 h before Testing
| Condition | E2 (pg/mg) | T (ng/mg) | 3α-diol (ng/mg) | 
|---|---|---|---|
| Aged, intact mice | |||
| Vehicle (n = 4) | 0.9 ± 0.2 | 0.3 ± 0.1 | 0.4 ± 0.1 | 
| E2 (n = 4) | 6.6 ± 1.3* | 0.6 ± 0.3 | 0.7 ± 0.1 | 
| T(n = 4) | 6.7 ± 1.2* | 2.6 ± 0.4* | 2.0 ± 0.4* | 
| 3α-diol (n = 4) | 1.3 ± 0.2 | 0.4 ± 0.1 | 3.2 ± 0.8* | 
| Young intact mice | |||
| Vehicle (n = 5) | 0.8 ± 0.4 | 1.0 ± 0.3 | 0.8 ± 0.4 | 
| E2 (n = 5) | 2.0 ± 0.2# | 0.6 ± 0.3 | 0.8 ± 0.4 | 
| T(n = 5) | 0.6 ± 0.2 | 1.8 ± 0.4 | 0.6 ± 0.2 | 
| 3α-diol (n = 5) | 0.8 ± 0.4 | 1.4 ± 0.4 | 2.0 ± 0.6 | 
| Young, GDX mice | |||
| Vehicle (n = 5) | 0.4 ± 0.3 | 0.4 ± 0.1 | 0.8 ± 0.2 | 
| E2(n = 5) | 0.6 ± 0.5 | 0.4 ± 0.2 | 0.3 ± 0.2 | 
| T(n = 5) | 0.7 ± 0.5 | 0.7 ± 0.1 | 1.3 ± 0.4 | 
| 3α-diol(n = 5) | 0.3 ± 0.2 | 0.4 ± 0.2 | 1.3 ± 0.2 | 
Denotes significant difference from vehicle (P< 0.05),
denotes tendency to be different from control (P<0.10).